Device Trial Radar · NCT06759935
Performance and Safety of LightForce® Therapy Lasers on Shoulder Soft Tissue Inflammation Pain Reduction
Last checked: Nov 19, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
104
Actual
Start
Feb 21, 2025
Primary completion
Mar 30, 2026
Study completion Mar 30, 2026
Sponsor
- Lead sponsor
- DJO UK LtdNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Donawa Lifescience Consulting S.r.l.
- First posted
- Jan 6, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
DJO UK Ltd (ENOVIS) is conducting this study to assess the effectiveness of LightForce® Therapy Lasers on pain reduction in shoulder soft tissue inflammation. In detail this study will assess superiority of LightForce® Therapy Lasers combined with standard of care, represented by physiotherapy/exercise program compared to sham laser combined with standard of care (physiotherapy/exercise program) on pain reduction in subjects with shoulder soft tissue inflammation due to Impingement (Subacromial impingement syndrome (SAIS)) or Rotator Cuff Tendinopathy (RCT),. In addition, this study allows to collect post market clinical data on the safety and performance of LightForce® Therapy Lasers, when used, following the normal clinical practice, in accordance with its approved and CE marked intended use.
Conditions
- Shoulder Pain
- Shoulder Impingement Syndrome
- Rotator Cuff Tendinitis
Interventions
Sham Laser therapyDevice
sham laser therapy for 4 consecutive weeks with a minimum of 3 sessions per week.
Laser therapyDevice
laser therapy for 4 consecutive weeks with a minimum of 3 sessions per week.
physiotherapy/exercise protocolOther
physiotherapy/exercise protocol represents the standard of care (SOC) and the program includes Codman's pendulum exercise, range of motion (ROM) exercises, stretching and isometric strengthening exercises, for 4 consecutive weeks with a minimum of 3 sessions per week.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain changeTime frame: 4 weeks after treatment start
Locations
10 sites in 3 countries. Site status is shown where the registry gives one.
Cabinet Attal
Serris, France
Casertafisio
Caserta, Italy
Rachis Center
Roma, Italy
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.